查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1704611

2025年感染疾病诊断检测全球市场报告

Infectious Disease Diagnostics Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年感染疾病诊断检测的市场规模将快速成长。到 2029 年，这一数字将成长至 625.8 亿美元，复合年增长率为 10.1%。预测期内的增长可归因于大流行性流感和 COVID-19 等新病原体的不断出现、向个性化和标靶治疗医疗的转变、对快速和现场检测解决方案的需求不断增加、对流行病学监测和早期检测系统的日益重视，以及专注于开发新型诊断技术和生物标誌物的研发活动的活性化。预测期内的关键趋势包括诊断设备的小型化和便携化、采用可同时检测多种病原体的多重检测、整合行动应用程式和远端医疗平台等数位健康解决方案、采用次世代定序(NGS) 技术进行感染疾病诊断、生物感测器技术的进步以实现快速灵敏的传染源检测，以及将人工智慧和机器学习演算法整合到诊断平台中。

由于呼吸道感染疾病的增加，感染疾病诊断检测市场预计将成长。呼吸道感染疾病影响呼吸系统的不同部位，是由病毒和细菌透过密切接触、不良卫生习惯、拥挤的居住环境、季节变化等传播引起的。感染疾病诊断检测对于准确识别和治疗呼吸道感染疾病至关重要，可以准确检测患者样本中的病毒和细菌等病原体。例如，加拿大卫生资讯研究所报告称，因急性上呼吸道感染疾病住院的人数增加了 32%，从 2022 年的 2,114 例增加到 2023 年的 2,797 例。

为了保持竞争力，感染疾病诊断检测市场的主要企业正专注于技术创新，尤其是分子诊断平台。这些平台是用于检测和分析生物样本中的核酸以用于诊断目的的先进系统。碧迪公司最近推出了 BD COR 系统，这是一个自动化感染疾病分子诊断平台，能够高通量处理多达 1,700 个检体，并在 24 小时内得出结果。该平台简化了分子实验室工作流程，提高了 HPV 和 STI 等疾病的诊断效率和准确性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球感染疾病诊断检测PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球感染疾病诊断检测市场：成长率分析
  • 全球感染疾病诊断检测市场表现：规模与成长，2019-2024
  • 全球感染疾病诊断检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球感染疾病诊断检测总目标市场（TAM）

第六章市场区隔

  • 全球感染疾病诊断检测市场类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 分子诊断检测
  • 照护现场检验（POCT）感染疾病诊断检测
  • 全球感染疾病诊断检测市场：应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 呼吸系统
  • 人类免疫力缺乏病毒（HIV）
  • 医院相关感染疾病（HAI）
  • 性健康
  • 热带疾病
  • 肝
  • 全球感染疾病诊断检测市场（按最终用户、绩效和预测）2019-2024 年、2024-2029 年、2034 年
  • 诊断实验室
  • 医院和诊所
  • 学术研究所
  • 其他最终用户
  • 全球感染疾病诊断检测市场按分子诊断检测类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）检测
  • 核酸增幅检查（NAAT）
  • 次世代定序（NGS）
  • 基于微阵列的侦测
  • 全球感染疾病诊断检测市场，依就地检验（POCT）感染疾病诊断检测类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 横向流动化验
  • 快速抗原检测
  • 免疫检测
  • 可携式PCR仪

第七章 区域和国家分析

  • 全球感染疾病诊断检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球感染疾病诊断检测市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 感染疾病诊断检测市场：竞争格局
  • 感染疾病诊断检测市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Becton Dickinson And Company
  • Quest Diagnostics Incorporated
  • Grifols SA
  • Hologic Inc.
  • PerkinElmer Inc.
  • bioMerieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • DiaSorin SpA（Luminex）
  • Myriad Genetics Inc.
  • Seegene Inc.
  • Ortho Clinical Diagnostics Inc.
  • OraSure Technologies Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年感染疾病诊断检测市场：提供新机会的国家
  • 2029年感染疾病诊断检测市场：细分领域带来新机会
  • 2029年感染疾病诊断检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r30473

Infectious disease diagnostics testing involves identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient's body. These tests are critical for diagnosing infectious diseases and making appropriate treatment decisions. They play a crucial role in controlling the spread of infectious diseases, guiding treatment choices, and monitoring outbreaks.

The main types of infectious disease diagnostics testing are molecular diagnostic tests and point-of-care tests (POCT) for infectious diseases. Molecular diagnostic testing refers to laboratory techniques that detect and analyze genetic material (DNA or RNA) to diagnose diseases, identify pathogens, and predict treatment responses. These tests find applications in areas such as respiratory infections, human immunodeficiency virus (HIV), healthcare-associated infections (HAIS), sexual health, tropical diseases, and liver diseases. They are utilized by various end-users including diagnostic laboratories, hospitals and clinics, academic research institutes, and other healthcare providers.

The infectious disease diagnostics testing market research report is one of a series of new reports from The Business Research Company that provides infectious disease diagnostics testing market statistics, including infectious disease diagnostics testing industry global market size, regional shares, competitors with an infectious disease diagnostics testing market share, detailed infectious disease diagnostics testing market segments, market trends, and opportunities, and any further data you may need to thrive in the infectious disease diagnostics testing industry. This infectious disease diagnostics testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infectious disease diagnostics testing market size has grown rapidly in recent years. It will grow from $38.52 billion in 2024 to $42.56 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising disease outbreaks such as SARS, Ebola, and Zika, growing awareness among healthcare professionals and the general public about the importance of early detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, control, and prevention, increasing global travel and trade have facilitated the spread of infectious diseases, and increased healthcare spending, particularly in emerging economies.

The infectious disease diagnostics testing market size is expected to see rapid growth in the next few years. It will grow to $62.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the shift towards personalized medicine and targeted therapies, increasing demand for rapid and on-site testing solutions, Growing emphasis on epidemiological surveillance and early detection systems, and increased research and developments activities focused on developing novel diagnostic technologies and biomarkers. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, such as mobile apps and telemedicine platforms, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies for rapid and sensitive detection of infectious agents, and integration of AI and machine learning algorithms into diagnostic platforms.

The infectious disease diagnostic testing market is anticipated to experience growth due to an increase in respiratory infections. Respiratory infections affect various parts of the respiratory system and are caused by viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal variations. Diagnostic testing for infectious diseases is crucial for accurate identification and treatment of respiratory infections, enabling the precise detection of pathogens such as viruses and bacteria in patient samples. For example, hospitalizations for acute upper respiratory infections saw a 32% increase from 2,114 cases in 2022 to 2,797 cases in 2023, as reported by the Canadian Institute for Health Information.

Leading companies in the infectious disease diagnostic testing market are focusing on innovation, particularly in molecular diagnostics platforms, to remain competitive. These platforms are sophisticated systems designed to detect and analyze nucleic acids from biological samples for diagnostic purposes. Becton Dickinson and Company recently launched the BD COR System, an automated infectious disease molecular diagnostics platform capable of high-throughput processing of up to 1,700 specimens with results delivered within 24 hours. This platform streamlines the molecular laboratory workflow, enhancing efficiency and diagnostic accuracy for diseases such as HPV and STIs.

In August 2022, SSI Diagnostica Group (SSID) acquired TechLab Inc., a US-based developer of infectious disease diagnostic products. This acquisition strengthens SSI Diagnostica Group's position in the infectious disease diagnostics market, aligning with their objectives of portfolio expansion, technological enhancement, and market share growth.

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease diagnostics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease diagnostics testing market consists of revenues earned by entities by providing services such as laboratory testing, point-of-care testing, molecular diagnostics, immunoassays, and rapid diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease diagnostics testing market also includes sales of diagnostic kits, reagents, instruments, and software used for detecting and identifying infectious agents in patients. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Diagnostics Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease diagnostics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease diagnostics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The infectious disease diagnostics testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Molecular Diagnostic Test; Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 2) By Application: Respiratory; Human Immunodeficiency Virus (HIV); Healthcare-Associated Infections (HAIs); Sexual Health; Tropical Diseases; Liver
  • 3) By End-User: Diagnostic Laboratories; Hospitals And Clinics; Academic Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests; Nucleic Acid Amplification Tests (NAATs); Next-Generation Sequencing (NGS); Microarray-Based Tests
  • 2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays; Rapid Antigen Tests; Immunoassays; Portable PCR
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infectious Disease Diagnostics Testing Market Characteristics

3. Infectious Disease Diagnostics Testing Market Trends And Strategies

4. Infectious Disease Diagnostics Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Infectious Disease Diagnostics Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Infectious Disease Diagnostics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Infectious Disease Diagnostics Testing Market Growth Rate Analysis
  • 5.4. Global Infectious Disease Diagnostics Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Infectious Disease Diagnostics Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Infectious Disease Diagnostics Testing Total Addressable Market (TAM)

6. Infectious Disease Diagnostics Testing Market Segmentation

  • 6.1. Global Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostic Test
  • Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 6.2. Global Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Respiratory
  • Human Immunodeficiency Virus (HIV)
  • Healthcare Associated Infections (HAIs)
  • Sexual Health
  • Tropical Diseases
  • Liver
  • 6.3. Global Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Laboratories
  • Hospitals And Clinics
  • Academic Research Institutes
  • Other End-Users
  • 6.4. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Tests
  • Nucleic Acid Amplification Tests (NAATs)
  • Next-Generation Sequencing (NGS)
  • Microarray-Based Tests
  • 6.5. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Point Of Care Tests (POCT) Infectious Disease Diagnostics Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lateral Flow Assays
  • Rapid Antigen Tests
  • Immunoassays
  • Portable PCR

7. Infectious Disease Diagnostics Testing Market Regional And Country Analysis

  • 7.1. Global Infectious Disease Diagnostics Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Infectious Disease Diagnostics Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease Diagnostics Testing Market

  • 8.1. Asia-Pacific Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease Diagnostics Testing Market

  • 9.1. China Infectious Disease Diagnostics Testing Market Overview
  • 9.2. China Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease Diagnostics Testing Market

  • 10.1. India Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease Diagnostics Testing Market

  • 11.1. Japan Infectious Disease Diagnostics Testing Market Overview
  • 11.2. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease Diagnostics Testing Market

  • 12.1. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease Diagnostics Testing Market

  • 13.1. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease Diagnostics Testing Market

  • 14.1. South Korea Infectious Disease Diagnostics Testing Market Overview
  • 14.2. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease Diagnostics Testing Market

  • 15.1. Western Europe Infectious Disease Diagnostics Testing Market Overview
  • 15.2. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease Diagnostics Testing Market

  • 16.1. UK Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease Diagnostics Testing Market

  • 17.1. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease Diagnostics Testing Market

  • 18.1. France Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease Diagnostics Testing Market

  • 19.1. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease Diagnostics Testing Market

  • 20.1. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease Diagnostics Testing Market

  • 21.1. Eastern Europe Infectious Disease Diagnostics Testing Market Overview
  • 21.2. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease Diagnostics Testing Market

  • 22.1. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease Diagnostics Testing Market

  • 23.1. North America Infectious Disease Diagnostics Testing Market Overview
  • 23.2. North America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease Diagnostics Testing Market

  • 24.1. USA Infectious Disease Diagnostics Testing Market Overview
  • 24.2. USA Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease Diagnostics Testing Market

  • 25.1. Canada Infectious Disease Diagnostics Testing Market Overview
  • 25.2. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease Diagnostics Testing Market

  • 26.1. South America Infectious Disease Diagnostics Testing Market Overview
  • 26.2. South America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease Diagnostics Testing Market

  • 27.1. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease Diagnostics Testing Market

  • 28.1. Middle East Infectious Disease Diagnostics Testing Market Overview
  • 28.2. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease Diagnostics Testing Market

  • 29.1. Africa Infectious Disease Diagnostics Testing Market Overview
  • 29.2. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease Diagnostics Testing Market Competitive Landscape And Company Profiles

  • 30.1. Infectious Disease Diagnostics Testing Market Competitive Landscape
  • 30.2. Infectious Disease Diagnostics Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease Diagnostics Testing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson And Company
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Grifols S.A.
  • 31.4. Hologic Inc.
  • 31.5. PerkinElmer Inc.
  • 31.6. bioMerieux SA
  • 31.7. Quidel Corporation
  • 31.8. Sysmex Corporation
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. QIAGEN N.V.
  • 31.11. DiaSorin SpA (Luminex)
  • 31.12. Myriad Genetics Inc.
  • 31.13. Seegene Inc.
  • 31.14. Ortho Clinical Diagnostics Inc.
  • 31.15. OraSure Technologies Inc.

32. Global Infectious Disease Diagnostics Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease Diagnostics Testing Market

34. Recent Developments In The Infectious Disease Diagnostics Testing Market

35. Infectious Disease Diagnostics Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Infectious Disease Diagnostics Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Infectious Disease Diagnostics Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Infectious Disease Diagnostics Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer